Luces y sombras de la medicina basada en la evidencia: El ejemplo del accidente vascular cerebral

Medicina Clinica

Volumn 116, Issue 9, 2001, Pages 343-349

  Chamorro, Ángel ^a   Alonso, Pedro ^a   Arrizabalaga, Jon ^b   Carné, Xavier ^a   Camps, Victòria ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b CSIC   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOETHICS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; MEDICAL RECORD; PATIENT ADVOCACY;

BIOETHICS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HEALTH CARE RATIONING; HEALTH POLICY; HUMANS; MEDICAL RECORDS; PATIENT ADVOCACY;

EID: 0035836164     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71822-2     Document Type: Article

References (28)

1. LaVera Crawley. Medicina basada en la evidencia: un nuevo paradigma para el paciente. En: Evidence-Based Medicine Working Group. La medicina basada en la evidencia. Guías del usuario de la literatura médica. Barcelona: JAMA (ed. esp.), Doyma, 1997; 22-23.
2. Martinez de Aragón MV, Llácer A. Mortalidad en España en 1992. Boletín Epidemiológico Semanal 1995; 3: 153-154.
3. Ackerknecht EH. Rudolf Virchow. Doctor Statesman Anthropologist. Madison: The University of Wisconsin Press, 1953.
4. Ackerknecht EH. Medicine at the Paris Hospital, 1794-1848. Baltimore: The Johns Hopkins University Press, 1967.
5. Cunningham A, Williams P. Introduction. En: Cunningham A, Williams P, editores. The laboratory revolution in medicine. Cambridge: Cambridge University Press, 1992; 1-13.
6. Lilienfeld AM. 'Ceteris paribus': the evolution of the clinical trial. Bulletin of the History of Medicine 1982; 56: 1-18.
7. Booth CC. Clinical research. En: Bynum W, Porter R, editores. Companion encyclopedia of the history of medicine. Londres-Nueva York: Routledge, 1993; 1: 205-229.
8. Marks HM. Trust and mistrust in the marketplace: statistics and clinical research, 1945-1960. History of Science 2000; 38: 343-355.
9. Evidence-Based Medicine Working Group. La medicina basada en la evidencia. Un nuevo enfoque para la docencia de la práctica de la medicina. En: Evidence Based Medicine Working Group. La medicina basada en la evidencia Guías del usuario de la literatura médica. Barcelona: JAMA (ed.esp.), Doyma, 1997; 15-21.
10. Daston L, Galison, P. The image of objectivity. Representations 1992; 40: 81-128.
11. Gol-Freixa, JM. Bienvenidos a la medicina basada en la evidencia. En: Evidence-Based Medicine Working Group. La medicina basada en la evidencia. Guías del usuario de la literatura médica. Barcelona: JAMA (ed. esp.), Doyma, 1997; 5-14.
12. Gol-Freixa, JM, Del Llano Señaris JE. El fenómeno de la «medicina basada en la evidencia». Med Clin (Barc) 1999; 112 (Supl 1): 3-8.
13. Pozo Rodríguez F. La medicina basada en la evidencia. Una perspectiva desde la clinica. Med Clin (Barc) 1999; 112 (Supl 1): 12-16.
14. Dunbabin DW, Sandercock PAG. Preventing stroke by modification of risk factors. Stroke 1990; 21 (Supl 4): 36-39.
15. Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
16. Algra A, Van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischemia. J Neurol Neurosurg Psychiatry 1996; 60: 197-199.
17. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
18. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
19. Chamorro A, Escolar G, Revilla M, Obach V, Vila N, Reverter JC et al. Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study. J Neurol Sci 1999; 171: 110-114.
20. Masuhr F, Busch M, Einhaupl KM. Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe. Stroke 1998; 29: 339-345.
21. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR et al, on behalf of the Syst-Eur Investigators. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-1351.
22. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C et al, for the PROACT Investigators. Intra-arterial prourokynase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. JAMA 1999; 282: 2003-2011.
23. Caro JJ, Migliaccio-Walle K, for the CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events. Am J Med 1999; 107: 568-572.
24. Gage BF, Boechler M, Doggette AL, Fortune G, Flaker GC, Rich MW et al Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 2000; 31: 822-827.
25. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PAC et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-1465.
26. Frith L. Evidence-based medicine and general practice. En: Dowrick C, Frith L, editores General practice and ethics. Nueva York: Routledge, 1999; 29-44.
27. Dowrick C. Uncertainty and responsibility. En: Dowrick C, Frith L, editores. General practice and ethics. Nueva York: Routledge, 1999; 13-28.
28. Dworkin R. El dominio de la vida. Barcelona: Ariel, 1994.